A review on molecular docking analysis of phytocompounds against SARS-CoV-2 druggable targets

References

• Abdelli I, Hassani F, Bekkel Brikci S, Ghalem S. 2020. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria. J Biomol Struct Dyn. 1–14. DOI:10.1080/07391102.2020.1763199
   Web of Science ®Google Scholar
• Adedeji AO, Lazarus H. 2016. Biochemical characterization of Middle East respiratory syndrome coronavirus helicase. mSphere. 1. DOI:10.1128/mSphere.00235-16
   Web of Science ®Google Scholar
• Ahmad S, Abbasi HW, Shahid S, et al. 2020. Molecular docking, simulation and MM-PBSA studies of Nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment. J Biomol Struct Dyn. 39, 12, 4225–4233. DOI:10.1080/07391102.2020.1775129
   Web of Science ®Google Scholar
• Ahn DG, Choi JK, Taylor DR, Oh JW. 2012. Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates. Arch Virol. 157:2095–2104. DOI:10.1007/s00705-012-1404-x
   PubMed Web of Science ®Google Scholar
• Ali A, Vijayan R. 2020. Dynamics of the ACE2–SARS-CoV-2/SARS-CoV spike protein interface reveal unique mechanisms. Sci Rep. 10:14214. DOI:10.1038/s41598-020-71188-3
   PubMed Web of Science ®Google Scholar
• Al Qaraghuli MM, Alzahrani AR, Niwasabutra K, et al. 2017. Where traditional drug discovery meets modern technology in the quest for new drugs. Ann Pharmacol Pharm. 2:1061.
   Google Scholar
• Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ. 2013. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio. 4. DOI:10.1128/mbio.00524-13
   Web of Science ®Google Scholar
• Arndt AL, Larson BJ, Hogue BG. 2010. A conserved domain in the coronavirus membrane protein tail is important for virus assembly. J Virol. 84:11418–11428. DOI:10.1128/jvi.01131-10
   PubMed Web of Science ®Google Scholar
• Asghari A, Naseri M, Safari H, et al. 2020. The novel insight of SARS-CoV-2 molecular biology and pathogenesis and therapeutic options. DNA Cell Biol. 39:1741–1753. DOI:10.1089/dna.2020.5703
   PubMed Web of Science ®Google Scholar
• Ayeleso T, Matumba M, Mukwevho E. 2017. Oleanolic acid and its derivatives: biological activities and therapeutic potential in chronic diseases. Molecules. 22:1915. DOI:10.3390/molecules22111915
   PubMed Web of Science ®Google Scholar
• Banerjee A, Kulcsar K, Misra V, et al. 2019. Bats and coronaviruses. Viruses. 11. 41, DOI:10.3390/v11010041
   PubMed Web of Science ®Google Scholar
• Basu A, Sarkar A, Maulik U. 2020. Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2. Sci Rep. 10. DOI:10.1038/s41598-020-74715-4
   Web of Science ®Google Scholar
• Beachboard DC, Anderson-Daniels JM, Denison MR. 2015. Mutations across murine hepatitis virus nsp4 alter virus fitness and membrane modifications. J Virol. 89:2080–2089. DOI:10.1128/JVI.02776-14
   PubMed Web of Science ®Google Scholar
• Beniac DR, Andonov A, Grudeski E, Booth TF. 2006. Architecture of the SARS coronavirus prefusion spike. Nat Struct Mol Biol. 13:751–752. DOI:10.1038/nsmb1123
   PubMed Web of Science ®Google Scholar
• Borkotoky S, Banerjee M. 2020. A computational prediction of SARS-CoV-2 structural protein inhibitors from Azadirachta indica (Neem). J Biomol Struct Dyn. 39, 11, 4111–4121. DOI:10.1080/07391102.2020.1774419
   Web of Science ®Google Scholar
• Bouvet M, Lugari A, Posthuma CC, et al. 2014. Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes. J Biol Chem. 289:25783–25796. DOI:10.1074/jbc.M114.577353.
   PubMed Web of Science ®Google Scholar
• Chan JFW, Chan KH, Kao RY, et al. 2013. Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus. J Infect. 67:606–616. DOI:10.1016/j.jinf.2013.09.029
   PubMed Web of Science ®Google Scholar
• Chan JFW, Kok KH, Zhu Z, et al. 2020. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 9:221–236. DOI:10.1080/22221751.2020.1719902
   PubMed Web of Science ®Google Scholar
• Chen H, Du Q. 2020. Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection. Preprints. DOI:10.20944/preprints202001.0358.v3
   Google Scholar
• Chen Y, Liu Q, Guo D. 2020. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 92:418–423. DOI:10.1002/jmv.25681
   PubMed Web of Science ®Google Scholar
• Chen Y, Su C, Ke M, et al. 2011. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2′-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog. 7:e1002294. DOI:10.1371/journal.ppat.1002294
   PubMed Web of Science ®Google Scholar
• Chowdhury P, Sahuc ME, Rouillé Y, et al. 2018. Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture. PLOS ONE. 13:e0198226.
   PubMed Web of Science ®Google Scholar
• Chuang M-T, Ho F-M, Wu C-C, Zhuang S-Y, Lin S-Y, Suk F-M, Liang Y-C. 2011. 15,16-Dihydrotanshinone I, a Compound of Salvia miltiorrhiza Bunge, Induces Apoptosis through Inducing Endoplasmic Reticular Stress in Human Prostate Carcinoma Cells. Evidence-Based Complementary and Alternative Medicine. 2011:1–9.
   Web of Science ®Google Scholar
• Conti P, Gallenga CE, Tetè G, et al. 2020. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 34. DOI:10.23812/Editorial-Conti-2
   Web of Science ®Google Scholar
• Cottam EM, Whelband MC, Wileman T. 2014. Coronavirus NSP6 restricts autophagosome expansion. Autophagy. 10:1426–1441. DOI:10.4161/auto.29309
   PubMed Web of Science ®Google Scholar
• Coutard B, Valle C, de Lamballerie X, et al. 2020. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 176:104742. DOI:10.1016/j.antiviral.2020.104742
   PubMed Web of Science ®Google Scholar
• Dai Y, Chen S-R, Chai L, et al. 2018. Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Crit Rev Food Sci Nutr. 59:S17–S29. DOI:10.1080/10408398.2018.1501657
   Web of Science ®Google Scholar
• Das S, Sarmah S, Lyndem S, Singha Roy A. 2020. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J Biomol Struct Dyn. 1–11. DOI:10.1080/07391102.2020.1763201
   Google Scholar
• Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 74:417–433. DOI:10.1128/mmbr.00016-10
   PubMed Web of Science ®Google Scholar
• Decroly E, Debarnot C, Ferron F, et al. 2011. Crystal structure and functional analysis of the SARS-coronavirus RNA Cap 2′-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog. 7:e1002059. DOI:10.1371/journal.ppat.1002059
   PubMed Web of Science ®Google Scholar
• DeDiego ML, Álvarez E, Almazán F, et al. 2007. A severe acute respiratory syndrome coronavirus that lacks the E gene is attenuated in vitro and in vivo. J Virol. 81:1701–1713. DOI:10.1128/JVI.01467-06
   PubMed Web of Science ®Google Scholar
• Dehelean CA, Şoica C, Ledeţi I, et al. 2012. Study of the betulin enriched birch bark extracts effects on human carcinoma cells and ear inflammation. Chem Cent J. 6. DOI:10.1186/1752-153x-6-137
   Google Scholar
• de Wit E, van Doremalen N, Falzarano D, Munster VJ. 2016. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 14:523–534. DOI:10.1038/nrmicro.2016.81
   PubMed Web of Science ®Google Scholar
• Dong Z, Lu X, Tong X, et al. 2017. Forsythiae fructus: a review on its phytochemistry, quality control, pharmacology and pharmacokinetics. Molecules. 22:1466. DOI:10.3390/molecules22091466
   PubMed Web of Science ®Google Scholar
• Egloff M-P, Ferron F, Campanacci V, et al. 2004. The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc Natl Acad Sci USA. 101:3792–3796. DOI:10.1073/pnas.0307877101
   PubMed Web of Science ®Google Scholar
• Enmozhi SK, Raja K, Sebastine I, Joseph J. 2020. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J Biomol Struct Dyn. 1–7. DOI:10.1080/07391102.2020.1760136
   Google Scholar
• Fang SG, Shen H, Wang J, et al. 2008. Proteolytic processing of polyproteins 1a and 1ab between non-structural proteins 10 and 11/12 of coronavirus infectious bronchitis virus is dispensable for viral replication in cultured cells. Virology. 379:175–180. DOI:10.1016/j.virol.2008.06.038
   PubMed Web of Science ®Google Scholar
• Fehr AR, Perlman S. 2015. Coronaviruses: an overview of their replication and pathogenesis. In: Maier H, Bickerton E, Britton P, editors. Coronaviruses. methods in molecular biology. New York, NY: Humana Press; p. 1–23.
   Google Scholar
• Fischer A, Sellner M, Neranjan S, et al. 2020. Potential inhibitors for novel coronavirus protease identified by virtual screening of 606 million compounds. Int J Mol Sci. 21:3626. DOI:10.3390/ijms21103626
   Web of Science ®Google Scholar
• Gadlage MJ, Sparks JS, Beachboard DC, et al. 2010. Murine hepatitis virus nonstructural protein 4 regulates virus-induced membrane modifications and replication complex function. J Virol. 84:280–290. DOI:10.1128/JVI.01772-09
   PubMed Web of Science ®Google Scholar
• Gallagher H, Williams JO, Ferekidis N, et al. 2019. Dihomo-γ-linolenic acid inhibits several key cellular processes associated with atherosclerosis. Biochim Biophys Acta (BBA) - Mol Basis Dis. 1865:2538–2550. DOI:10.1016/j.bbadis.2019.06.011
   Web of Science ®Google Scholar
• Ganjhu RK, Mudgal PP, Maity H, et al. 2015. Herbal plants and plant preparations as remedial approach for viral diseases. VirusDisease. 26:225–236. DOI:10.1007/s13337-015-0276-6
   PubMedGoogle Scholar
• Gautret P, Lagier J-C, Parola P, et al. 2020. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non-randomized clinical trial. Int J Antimicrob Agents. 56, 1, 105949. DOI:10.1016/j.ijantimicag.2020.105949
   PubMed Web of Science ®Google Scholar
• Graepel KW, Lu X, Case JB, et al. 2017. Proofreading-deficient coronaviruses adapt for increased fitness over long-term passage without reversion of exoribonuclease-inactivating mutations. mBio. 8. DOI:10.1128/mBio.01503-17
   Web of Science ®Google Scholar
• Graham RL, Donaldson EF, Baric RS. 2013. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol. 11:836–848. DOI:10.1038/nrmicro3143
   PubMed Web of Science ®Google Scholar
• Gyebi GA, Ogunro OB, Adegunloye AP, et al. 2020. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants. J Biomol Struct Dyn. 1–13. DOI:10.1080/07391102.2020.1764868
   Web of Science ®Google Scholar
• Hackbart M, Deng X, Baker SC. 2020. Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors. Proc Natl Acad Sci USA. 117:8094–8103. DOI:10.1073/pnas.1921485117
   PubMed Web of Science ®Google Scholar
• Hao W, Wojdyla JA, Zhao R, et al. 2017. Crystal structure of Middle East respiratory syndrome coronavirus helicase. PLoS Pathog. 13:e1006474. DOI:10.1371/journal.ppat.1006474
   PubMed Web of Science ®Google Scholar
• Harapan H, Itoh N, Yufika A, et al. 2020. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 13:667–673. DOI:10.1016/j.jiph.2020.03.019
   PubMed Web of Science ®Google Scholar
• Harcourt BH, Jukneliene D, Kanjanahaluethai A, et al. 2004. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol. 78:13600–13612. DOI:10.1128/jvi.78.24.13600-13612.2004
   PubMed Web of Science ®Google Scholar
• Hemida MG, Ba Abduallah MM. 2020. The SARS-CoV-2 outbreak from a one health perspective. One Health. 10, 100127. DOI:10.1016/j.onehlt.2020.100127
   PubMed Web of Science ®Google Scholar
• Hu X, Cai X, Song X, et al. 2020. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Future Virol. 15, 6, 359–368. DOI:10.2217/fvl-2020-0099
   Web of Science ®Google Scholar
• Imran M, Salehi B, Sharifi-Rad J, et al. 2019. Kaempferol: a key emphasis to its anticancer potential. Molecules. 24:2277. DOI:10.3390/molecules24122277
   PubMed Web of Science ®Google Scholar
• Isaacson MK, Ploegh HL. 2009. Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe. 5:559–570. DOI:10.1016/j.chom.2009.05.012
   PubMed Web of Science ®Google Scholar
• Islam R, Parves MR, Paul AS, et al. 2020. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. J Biomol Struct Dyn. 1–12. DOI:10.1080/07391102.2020.1761883
   Web of Science ®Google Scholar
• Jamiu AT, Aruwa CE, Abdulakeem IA, et al. 2020. Phytotherapeutic evidence against coronaviruses and prospects for COVID-19. Pharmacognosy Journal. 12:1252–1267. DOI:10.5530/pj.2020.12.174
   Google Scholar
• Jesus JA, Lago JHG, Laurenti MD, et al. 2015. Antimicrobial activity of oleanolic and ursolic acids: an update. Evidence-Based Complementary Altern Med. 2015:1–14. DOI:10.1155/2015/620472
   Web of Science ®Google Scholar
• Jia Z, Yan L, Ren Z, et al. 2019. Delicate structural coordination of the severe acute respiratory syndrome coronavirus Nsp13 upon ATP hydrolysis. Nucleic Acids Res. 47:6538–6550. DOI:10.1093/nar/gkz409
   PubMed Web of Science ®Google Scholar
• Kapetanovic IM. 2008. Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach. Chem-Biol Interact. 171:165–176. DOI:10.1016/j.cbi.2006.12.006
   PubMed Web of Science ®Google Scholar
• Kar P, Sharma NR, Singh B, et al. 2020. Natural compounds from Clerodendrum spp. as possible therapeutic candidates against SARS-CoV-2: An in silico investigation. J Biomol Struct Dyn. 39, 13, 4774–4785. DOI:10.1080/07391102.2020.1780947
   Web of Science ®Google Scholar
• Kaur R, Manjal SK, Rawal RK, Kumar K. 2017. Recent synthetic and medicinal perspectives of tryptanthrin. Bioorg Med Chem. 25:4533–4552. DOI:10.1016/j.bmc.2017.07.003
   Web of Science ®Google Scholar
• Kim S, Chen J, Cheng T, et al. 2019. Pubchem 2019 update: improved access to chemical data. Nucleic Acids Res. 47:D1102–D1109. DOI:10.1093/nar/gky1033
   PubMed Web of Science ®Google Scholar
• Kim Y, Jedrzejczak R, Maltseva NI, et al. 2020. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV -2. Protein Sci. 29, 7, 1596–1605. DOI:10.1002/pro.3873
   PubMed Web of Science ®Google Scholar
• Kirchdoerfer RN, Ward AB. 2019. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun. 10. DOI:10.1038/s41467-019-10280-3
   Web of Science ®Google Scholar
• Koval’skii IV, Krasnyuk II, Krasnyuk II, et al. 2014. Mechanisms of rutin pharmacological action (review). Pharm Chem J. 48:73–76. DOI:10.1007/s11094-014-1050-6
   Web of Science ®Google Scholar
• Kumar A, Choudhir G, Shukla SK, et al. 2020. Identification of phytochemical inhibitors against main protease of COVID-19 using molecular modeling approaches. J Biomol Struct Dyn. 39, 10, 3760–3770. DOI:10.1016/j.jpha.2020.03.001
   PubMed Web of Science ®Google Scholar
• Kumar V, Dhanjal JK, Kaul SC, et al. 2020. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn. 39, 11, 3842–3854. DOI:10.1016/j.jpha.2020.03.001
   Web of Science ®Google Scholar
• Kuo L, Hurst-Hess KR, Koetzner CA, Masters PS. 2016. Analyses of coronavirus assembly Interactions with interspecies membrane and nucleocapsid protein chimeras. J Virol. 90:4357–4368. DOI:10.1128/jvi.03212-15
   PubMed Web of Science ®Google Scholar
• Lei J, Kusov Y, Hilgenfeld R. 2018. Nsp3 of coronaviruses: structures and functions of a large multi-domain protein. Antiviral Res. 149:58–74. DOI:10.1016/j.antiviral.2017.11.001
   PubMed Web of Science ®Google Scholar
• Li H, Liu SM, Yu XH, et al. 2020. Coronavirus disease 2019 (COVID-19): current status and future perspective. Int J Antimicrob Agents. 55, 5, 105951. DOI:10.1016/j.ijantimicag.2020.105951
   PubMed Web of Science ®Google Scholar
• Li W, Moore MJ, Vasilieva N, et al. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426:450–454. DOI:10.1038/nature02145
   PubMed Web of Science ®Google Scholar
• Li X, Geng M, Peng Y, et al. 2020. Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal. DOI:10.1016/j.jpha.2020.03.001
   Web of Science ®Google Scholar
• Ling LJ, Lu Y, Zhang YY, et al. 2020. Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and toll-like receptor signalling. Phytomedicine. 67:153150. DOI:10.1016/j.phymed.2019.153150
   PubMed Web of Science ®Google Scholar
• Liu M, Yu Q, Yi Y, et al. 2020. Antiviral activities of Lonicera japonica thunb. components against grouper iridovirus in vitro and in vivo. Aquaculture. 519:734882. DOI:10.1016/j.aquaculture.2019.734882
   Web of Science ®Google Scholar
• Lu R, Zhao X, Li J, et al. 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 395, 10224, 565–574. DOI:10.2139/ssrn.3583748
   PubMed Web of Science ®Google Scholar
• Lung J, Lin Y, Yang Y, et al. 2020. The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. J Med Virol. 92:693–697. DOI:10.1002/jmv.25761
   PubMed Web of Science ®Google Scholar
• Luo Y, Wang CZ, Hesse-Fong J, et al. 2019. Application of Chinese medicine in acute and critical medical conditions. Am J Chin Med. 47:1223–1235. DOI:10.1142/s0192415(19500629
   PubMed Web of Science ®Google Scholar
• Ma Y, Wu L, Shaw N, et al. 2015. Structural basis and functional analysis of the SARS coronavirus nsp14–nsp10 complex. Proc Natl Acad Sci USA. 112:9436–9441. DOI:10.1073/pnas.1508686112
   PubMed Web of Science ®Google Scholar
• Mani JS, Johnson JB, Steel JC, et al. 2020. Natural product-derived phytochemicals as potential agents against coronaviruses: a review. Virus Res. 284:197989. DOI:10.1016/j.virusres.2020.197989
   PubMed Web of Science ®Google Scholar
• Marinelli L, Fornasari E, Eusepi P, et al. 2019. Carvacrol prodrugs as novel antimicrobial agents. Eur J Med Chem. 178:515–529. DOI:10.1016/j.ejmech.2019.05.093
   PubMed Web of Science ®Google Scholar
• Mishra RC, Kumari R, Yadav S, Yadav JP. 2020. Antiviral potential of phytoligands against chymotrypsin-like protease of COVID-19 virus using molecular docking studies: an optimistic approach. Research Square Prepri. DOI:10.2139/ssrn.3583748
   Google Scholar
• Miyaichi Y, Segawa A, Tomimori T. 2006. Studies on Nepalese crude drugs. XXIX. Chemical constituents of dronapuspi, the whole herb of Leucas cephalotes SPRENG. Chem Pharm Bull. 54:1370–1379. DOI:10.1248/cpb.54.1370
   Web of Science ®Google Scholar
• Mohamed K, Yazdanpanah N, Saghazadeh A, Rezaei N. 2020. Computational drug discovery and repurposing for the treatment of COVID-19: a systematic review. SSRN Electronic Journal. DOI:10.2139/ssrn.3583748
   Google Scholar
• Mohammadi N, Shaghaghi N. 2020. Inhibitory effect of eight secondary metabolites from conventional medicinal plants on COVID_19 virus protease by molecular docking analysis. ChemRxiv. DOI:10.26434/chemrxiv.11987475.v1
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 6:e1000097. DOI:10.1371/journal.pmed.1000097
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Shah F, Desai P, Avery M. 2011. Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies. J Chem Inf Model. 51:1376–1392. DOI:10.1021/ci1004916
   Web of Science ®Google Scholar
• Murugan NA, Pandian CJ, Jeyakanthan J. 2020. Computational investigation on Andrographis paniculata phytochemicals to evaluate their potency against SARS-CoV-2 in comparison to known antiviral compounds in drug trials. J Biomol Struct Dyn. 39, 12, 4415–4426. DOI:10.1080/07391102.2020.1777901
   Web of Science ®Google Scholar
• Nal B, Chan C, Kien F, et al. 2005. Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol. 86:1423–1434. DOI:10.1099/vir.0.80671-0
   Web of Science ®Google Scholar
• Naqvi AAT, Fatima K, Mohammad T, et al. 2020. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach. Biochim Biophys Acta Mol Basis Dis. 1866:165878. DOI:10.1016/j.bbadis.2020.165878
   PubMed Web of Science ®Google Scholar
• Neelam S, Gokara M, Sudhamalla B, et al. 2010. Interaction studies of coumaroyltyramine with human serum albumin and its biological importance. J Phys Chem B. 114:3005–3012. DOI:10.1021/jp910156k
   PubMed Web of Science ®Google Scholar
• Neuman BW, Kiss G, Kunding AH, et al. 2011. A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol. 174:11–22. DOI:10.1016/j.jsb.2010.11.021
   PubMed Web of Science ®Google Scholar
• Nieto-Torres JL, DeDiego ML, Verdiá-Báguena C, et al. 2014. Severe acute respiratory syndrome coronavirus envelope protein Ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog. 10:e1004077. DOI:10.1371/journal.ppat.1004077
   PubMed Web of Science ®Google Scholar
• Omrani AS, Saad MM, Baig K, et al. 2014. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Lancet Infect Dis. 14:1090–1095. DOI:10.1016/s1473-3099(14)70920-x
   PubMed Web of Science ®Google Scholar
• Ortega JT, Serrano ML, Pujol FH, Rangel HR. 2020. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis. EXCLI J. 19:410–417. DOI:10.17179/excli2020-1167
   PubMed Web of Science ®Google Scholar
• Raj VS, Mou H, Smits SL, et al. 2013. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 495:251–254. DOI:10.1038/nature12005
   PubMed Web of Science ®Google Scholar
• Rane JS, Chatterjee A, Kumar A, Ray S. 2020. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silco study for drug development. chemrxivorg. DOI:10.3389/fphar.2018.00481
   Google Scholar
• Saeed MEM, Mahmoud N, Sugimoto Y, et al. 2018. Betulinic acid exerts cytotoxic activity against multidrug-resistant tumor cells via targeting autocrine motility factor receptor (AMFR). Front Pharmacol. 9. DOI:10.3389/fphar.2018.00481
   Google Scholar
• Sampangi-Ramaiah HM, Vishwakarma R, Shaanker RU. 2020. Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease. Curr Sci. 118:1087–1092. DOI:10.18520/cs/v118/i7/1087-1092
   Web of Science ®Google Scholar
• Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. 2020. Pharmacologic treatments for coronavirus disease 2019 (COVID-19). JAMA.DOI:10.1001/jama.2020.6019
   PubMed Web of Science ®Google Scholar
• Santos FA, Frota JT, Arruda BR, et al. 2012. Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice. Lipids Health Dis. 11. DOI:10.1186/1476-511x-11-98
   Google Scholar
• Schoeman D, Fielding BC. 2019. Coronavirus envelope protein: current knowledge. Virol J. 16. DOI:10.1186/s12985-019-1182-0
   Google Scholar
• Shang Q, Xu H, Huang L. 2012. Tanshinone IIA: a promising natural cardioprotective agent. Evidence-Based Complementary Altern Med. 2012:1–7. DOI:10.1155/2012/716459.
   Web of Science ®Google Scholar
• Shereen MA, Khan S, Kazmi A, et al. 2020. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res. 24, 91–98. DOI:10.1016/j.jare.2020.03.005
   PubMed Web of Science ®Google Scholar
• Shi P, Su Y, Li R, et al. 2019. PEDV nsp16 negatively regulates innate immunity to promote viral proliferation. Virus Res. 265:57–66. DOI:10.1016/j.virusres.2019.03.005
   PubMed Web of Science ®Google Scholar
• Shode FO, Idowu ASK, Uhomoibhi OJ, Sabiu S. 2021. Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2. J Biomol Struct Dyn. 1–16. DOI:10.1080/07391102.2021.1886993
   Google Scholar
• Silvestrini L, Belhaj N, Comez L, Gerelli Y, Lauria A, Libera V, Mariani P, Marzullo P, Ortore MG, Piccionello A, et al. 2021. The dimer-monomer equilibrium of SARS-CoV-2 main protease is affected by small molecule inhibitors. Sci Rep. 11,. DOI:10.1038/s41598-021-88630-9
   Google Scholar
• Singh A, Mishra A. 2020. Leucoefdin a potential inhibitor against SARS CoV-2 mpro. J Biomol Struct Dyn. 39, 12, 4427–4432. DOI:10.1080/07391102.2020.1777903
   Web of Science ®Google Scholar
• Sinha SK, Prasad SK, Islam MA, et al. 2020. Identification of bioactive compounds from Glycyrrhiza glabra as possible inhibitor of SARS-CoV-2 spike glycoprotein and non-structural protein-15: a pharmacoinformatics study. J Biomol Struct Dyn. 39, 13, 4686–4700. DOI:10.1080/07391102.2020.1779132
   Web of Science ®Google Scholar
• Sun J, He WT, Wang L, et al. 2020. COVID-19: epidemiology, evolution, and cross-disciplinary perspectives. Trends Mol Med. 26, 5, 483–495. DOI:10.1016/j.molmed.2020.02.008
   PubMed Web of Science ®Google Scholar
• Sutton G, Fry E, Carter L, et al. 2004. The nsp9 replicase protein of SARS-coronavirus, structure and functional insights. Structure. 12:341–353. DOI:10.1016/j.str.2004.01.016.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kamitani W, Dediego M L, Enjuanes L, Matsuura Y. 2012. Severe Acute Respiratory Syndrome Coronavirus nsp1 Facilitates Efficient Propagation in Cells through a Specific Translational Shutoff of Host mRNA. Journal of Virology. 86(20):11128–11137.
   PubMed Web of Science ®Google Scholar
• Tekpinar M, Yildirim A. 2021. Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases. J Biomol Struct Dyn. 1–12. DOI:10.1080/07391102.2021.1880481
   Google Scholar
• te Velthuis AJW, van den Worm SHE, Snijder EJ. 2012. The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension. Nucleic Acids Res. 40:1737–1747. DOI:10.1093/nar/gkr893
   PubMed Web of Science ®Google Scholar
• Thirupathaiah A, Rao GV, Takaishi Y. 2015. A lignan from the roots of Crossandra nilotica. Biomed Pharmacol J. 1:311–314.
   Google Scholar
• Tsai YC, Lee CL, Yen HR, et al. 2020. Antiviral action of tryptanthrin isolated from Strobilanthes cusia leaf against human coronavirus NL63. Biomolecules. 10:366. DOI:10.3390/biom10030366
   PubMed Web of Science ®Google Scholar
• ul Qamar MT, Alqahtani SM, Alamri MA, Chen LL. 2020. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 10, 4, 313–319. DOI:10.1016/j.jpha.2020.03.009
   PubMed Web of Science ®Google Scholar
• Umesh KD, Selvaraj C, et al. 2020. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. J Biomol Struct Dyn. 1–9. DOI:10.1080/07391102.2020.1763202
   Google Scholar
• van de Waterbeemd H, Gifford E. 2003. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discovery. 2:192–204. DOI:10.1038/nrd1032
   PubMed Web of Science ®Google Scholar
• Wahedi HM, Ahmad S, Abbasi SW. 2020. Stilbene-based natural compounds as promising drug candidates against COVID-19. J Biomol Struct Dyn. 1–10. DOI:10.1080/07391102.2020.1762743
   Google Scholar
• Wang M, Cao R, Zhang L, et al. 2020. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 3, 269–271. DOI:10.1038/s41422-020-0282-0
   PubMed Web of Science ®Google Scholar
• Wang X, Lin H, Gu Y. 2012. Multiple roles of dihomo-γ-linolenic acid against proliferation diseases. Lipids Health Dis. 11:25. DOI:10.1186/1476-511x-11-25
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen X, Lu Y, et al. 2020. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 14, 1, 64–68. DOI:10.5582/bst.2020.01030
   PubMed Web of Science ®Google Scholar
• Weathers PJ, Towler M, Hassanali A, et al. 2014. Dried-leaf artemisia annua: a practical malaria therapeutic for developing countries? World J Pharmacol. 3:39–55. DOI:10.5497/wjp.v3.i4.39
   PubMedGoogle Scholar
• Weaver BA. 2014. How taxol/paclitaxel kills cancer cells. Mol Biol Cell. 25:2677–2681. DOI:10.1091/mbc.e14-04-0916
   PubMed Web of Science ®Google Scholar
• Wishart DS, Feunang YD, Marcu A, et al. 2018. HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res. 46:D608–D617. DOI:10.1093/nar/gkx1089
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). 2021. Coronavirus disease pandemic. [cited 2021 Mar 22].Available from: https://covid19.who.int/
   Google Scholar
• Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, et al. 2020. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B. 10(5).
   Web of Science ®Google Scholar
• Xia X. 2017. Bioinformatics and drug discovery. Curr Top Med Chem. 17:1709–1726. DOI:10.2174/1568026617666161116143440
   PubMedGoogle Scholar
• Xian Y, Zhang J, Bian Z, et al. 2020. Bioactive natural compounds against human coronaviruses: a review and perspective. Acta Pharm Sin B. 10, 7, 1163–1174. DOI:10.1016/j.apsb.2020.06.002
   PubMed Web of Science ®Google Scholar
• Yang D, Leibowitz JL. 2015. The structure and functions of coronavirus genomic 3′ and 5′ ends. Virus Res. 206:120–133. DOI:10.1016/j.virusres.2015.02.025
   PubMed Web of Science ®Google Scholar
• Yang H, Yang M, Ding Y, et al. 2003. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci USA. 100:13190–13195. DOI:10.1073/pnas.1835675100
   PubMed Web of Science ®Google Scholar
• Yang ZF, Bai LP, Huang Wb, et al. 2014. Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure–activity relationship analysis. Fitoterapia. 93:47–53. DOI:10.1016/j.fitote.2013.12.011
   PubMed Web of Science ®Google Scholar
• Yi L, Li Z, Yuan K, et al. 2004. Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. J Virol. 78:11334–11339. DOI:10.1128/JVI.78.20.11334-11339.2004
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Niki E. 2003. Antioxidant effects of phytosterol and its components. J Nutr Sci Vitaminol. 49:277–280. DOI:10.3177/jnsv.49.277
   PubMed Web of Science ®Google Scholar
• Yu R, Chen L, Lan R, et al. 2020. Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. Int J Antimicrob Agents. 56 106012. DOI:10.1016/j.ijantimicag.2020.106012
   PubMed Web of Science ®Google Scholar
• Zakaryan H, Arabyan E, Oo A, Zandi K. 2017. Flavonoids: promising natural compounds against viral infections. Arch Virol. 162:2539–2551. DOI:10.1007/s00705-017-3417-y
   PubMed Web of Science ®Google Scholar
• Zeng J, Fan Y, Tan B, et al. 2018. Charactering the metabolism of cryptotanshinone by human P450 enzymes and uridine diphosphate glucuronosyltransferases in vitro. Acta Pharmacol Sin. 39:1393–1404. DOI:10.1038/aps.2017.144
   Web of Science ®Google Scholar
• Zeng Z, Deng F, Shi K, et al. 2018. Dimerization of coronavirus nsp9 with diverse modes enhances its nucleic acid binding affinity. J Virol. 92. DOI:10.1128/JVI.00692-18
   Google Scholar
• Zhai Y, Sun F, Li X, et al. 2005. Insights into SARS-CoV transcription and replication from the structure of the nsp7–nsp8 hexadecamer. Nat Struct Mol Biol. 12:980–986. DOI:10.1038/nsmb999
   PubMed Web of Science ®Google Scholar
• Zhang D, Wu K, Zhang X, et al. 2020. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J Integr Med. 18:152–158. DOI:10.1016/j.joim.2020.02.005
   PubMed Web of Science ®Google Scholar
• Zhang J, Xie B, Hashimoto K. 2020. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behav Immun. DOI:10.1038/s41586-020-2012-7
   Google Scholar
• Zhang X, Hu J, Chen Y. 2016. Betulinic acid and the pharmacological effects of tumor suppression. Mol Med Rep. 14:4489–4495. DOI:10.3892/mmr.2016.5792
   Web of Science ®Google Scholar
• Zhou J, Fang L, Yang Z, et al. 2019. Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach. FASEB J. 33:14575–14587. DOI:10.1096/fj.201901624rr
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579, 7798, 270–273. DOI:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Ziebuhr J, Gorbalenya AE, Snijder EJ. 2000. Virus-encoded proteinases and proteolytic processing in the nidovirales. J Gen Virol. 81:853–879. DOI:10.1099/0022-1317-81-4-853
   PubMed Web of Science ®Google Scholar
• Zumla A, Hui DS, Perlman S. 2015. Middle East respiratory syndrome. The Lancet. 386:995–1007. DOI:10.1016/s0140-6736(15)60454-8
   PubMed Web of Science ®Google Scholar